Edinburgh-based Carbogenics, which has developed proprietary technology that boosts green energy production, has raised more than £1 million in investment to build its first production and R&D facility in Scotland.
Glasgow-based firm N4 Ventures, spearheaded by Gordon Merrylees, previously the managing director of entrepreneurship at NatWest, RBS, and Ulster Bank, has announced the initiation of its inaugural venture capital fund following regulatory approval from the Financial Conduct Authority (FCA).
Johnston Carmichael has appointed Roy Hogg and John Gold to its Stirling team as business advisory partner and business advisory director, respectively, expanding its business capabilities.
Edinburgh-based technology startup Inicio AI, known for making debt management more efficient for businesses and less stressful for consumers, has successfully secured more than £500,000 in an ongoing £1 million fundraising round.
Scottish gold producer Scotgold Resources has been challenged with an imminent leadership change after its CEO, Phil Day, announced his intention to resign.
Cross-border advisory firm, Quantuma, has appointed seasoned restructuring advisory professional Alistair Dickson as a managing director in its Glasgow office.
St Andrews-based biotech firm Pneumagen has secured £8 million in financing from existing and new investors to support the continued Phase 2 development of Neumifil, a broad-spectrum antiviral, intranasal drug for the prophylaxis and treatment of viral respiratory tract infections (RTIs).
Scottish accountancy firm, Johnston Carmichael, has expanded its senior management ranks with three new director promotions as part of its strategic leadership growth plan.
Equity Gap, the Edinburgh-based angel investment syndicate has today announced changes to its top team that will see the syndicate continue to expand its portfolio across Scotland and the UK.
Scotland’s economy demonstrated robust growth in the first quarter of 2023, outpacing the UK average, according to recent data released by the chief statistician.
German science and technology giant, Merck, has announced plans to invest €35 million (£30m) in the expansion of its biosafety testing capabilities in Glasgow and Stirling.